Feeds:
Posts
Comments

Search Results for 'Statins'

Reversing Heart Disease: Combination of PCSK9 Inhibitors and Statins – Opinion by Steven Nissen, MD, Chairman of Cardiovascular Medicine at Cleveland Clinic

Posted in Atherogenic Processes & Pathology, Frontiers in Cardiology and Cardiovascular Disorders, Origins of Cardiovascular Disease, PCSK9 Inhibitor Therapy, Pharmacotherapy of Cardiovascular Disease, Vascular Diseases, tagged , , , , on December 29, 2016| Leave a Comment »


Reversing Heart Disease: Combination of PCSK9 Inhibitors and Statins – Opinion by Steven Nissen, MD, Chairman of Cardiovascular Medicine at Cleveland Clinic Reporter: Aviva Lev-Ari, PhD, RN UPDATED on 2/25/2019 https://www.medpagetoday.com/cardiology/prevention/78202?xid=nl_mpt_SRCardiology_2019-02-25&eun=g99985d0r&utm_source=Sailthru&utm_medium=email&utm_campaign=CardioUpdate_022519&utm_term=NL_Spec_Cardiology_Update_Active While nearly 10% of middle-age adults in China have high risk for cardiovascular disease, only 0.6% of these high-risk individuals use statins and 2.4% […]

Read Full Post »

Perioperative Statins at Noncardiac Surgery: Survival Up, Complications Down

Posted in Perioperative Statins at Noncardiac Surgery on December 27, 2016| Leave a Comment »


Perioperative Statins at Noncardiac Surgery: Survival Up, Complications Down Reporter: Aviva Lev-Ari, PhD, RN   UPDATED on 11/26/2018   Clinical Trial: Statins Evaluation in Coronary Procedures and Revascularization (SECURE-PCI) A Cardio-Endo Connection selection by Dharam J. Kumbhani, MD, SM (Trial Summary); Deepak L. Bhatt, MD, MPH (Summary Reviewer) Contribution to Literature: The Statins Evaluation in Coronary […]

Read Full Post »

What’s the Story with Statins and Stroke Prevention? – A Q&A with Koto Ishida, MD – HCPLive

Posted in Uncategorized on January 30, 2015| Leave a Comment »


What’s the Story with Statins and Stroke Prevention? – A Q&A with Koto Ishida, MD HCPLive My patients are at high risk for future cardiovascular (CV) events; most have already had a stroke or a transient ischemic attack (TIA). Source: news.google.com See on Scoop.it – Cardiovascular and vascular imaging

Read Full Post »

Guideline Critics Shift Attacks From Beta Blockers To Statins – Forbes

Posted in Uncategorized on August 4, 2014| Leave a Comment »


Guideline Critics Shift Attacks From Beta Blockers To Statins Forbes With the release today of updated European and US guidelines the ongoing controversy regarding beta-blockers appears to be resolved. Source: http://www.forbes.com See on Scoop.it – Cardiovascular Disease: PHARMACO-THERAPY

Read Full Post »

Statins in Very Elderly Adults (Debate) – Medscape

Posted in Scoop.it on July 1, 2014| Leave a Comment »


Medscape Statins in Very Elderly Adults (Debate) Medscape It contrasted the effects of intensive statin therapy with those of moderate statin therapy on reduction of myocardial ischemia in participants.

Read Full Post »

Statins cut limb events in PAD patients – Family Practice News Digital Network

Posted in Uncategorized on September 16, 2013| Leave a Comment »


See on Scoop.it – Cardiovascular and vascular imaging Statins cut limb events in PAD patients Family Practice News Digital Network “This is one of the first, and largest, studies to demonstrate an impact [of statin treatment] on adverse limb outcomes in patients with PAD, including worsening… See on http://www.familypracticenews.com

Read Full Post »

Statins’ Nonlipid Effects on Vascular Endothelium through eNOS Activation

Posted in Biological Networks, Gene Regulation and Evolution, Cardiovascular Pharmacogenomics, Cell Biology, Signaling & Cell Circuits, Disease Biology, Small Molecules in Development of Therapeutic Drugs, HTN, Metabolomics, Molecular Genetics & Pharmaceutical, Nitric Oxide in Health and Disease, Origins of Cardiovascular Disease, Pharmacotherapy of Cardiovascular Disease, Proteomics, tagged , , , on October 8, 2012| 20 Comments »


Statins’ Nonlipid Effects on Vascular Endothelium through eNOS Activation   Curator, Author,Writer, Reporter: Larry Bernstein, MD, FACP   Categories of Research: Disease biology, Cell Biology and Cell Signaling, Biological Networks and Gene Regulation, Pharmacotherapy of Cardiovascular Disease, Nitric Oxide, HMG Co A inhibitors, Endothelial Receptor, Hypertension, Therapeutic Targets Introduction Statins have an effect on the […]

Read Full Post »

Noam Steiner Tomer, Summer Internship, Research Assistant 1

Posted in on June 17, 2020|


Noam Steiner Tomer, Summer Internship, Research Assistant 1 https://pharmaceuticalintelligence.com/contributors-biographies/research-assistants/noam-steiner-tomer-summer-internship-research-assistant-1/ 7/3/2020 Leukemia and Lymphoma Mutations Title Gene(s) Imatinib (Gleevec) May Help Treat Aggressive Lymphoma: Chronic Lymphocytic Leukemia (CLL) ABL/BCR, p53, 17q Sunitinib brings Adult Acute Lymphoblastic Leukemia (ALL) to Remission – RNA Sequencing – FLT3 Receptor Blockade FLT3 Metabolomic analysis of two leukemia cell lines. II. ZAP-70(+), […]

Read Full Post »

SAR-Cov-2 is probably a vasculotropic RNA virus affecting the blood vessels: Endothelial cell infection and endotheliitis in COVID-19

Posted in COVID-19, Population Health Management, Genetics & Pharmaceutical, SAR-Cov-2 a vasculotropic (blood vessels) RNA Virus, SARS-CoV-2, Treatment Protocols for COVID-19, Virus Infective Acute Respiratory Syndrome: SARS-CoV on June 1, 2020| Leave a Comment »


SAR-Cov-2 is probably a vasculotropic RNA virus affecting the blood vessels: Endothelial cell infection and endotheliitis in COVID-19 Reporter: Aviva Lev-Ari, PhD, RN – Bold face and colors are my addition From: “Dr. Larry Bernstein” <larry.bernstein@gmail.com> Reply-To: “Dr. Larry Bernstein” <larry.bernstein@gmail.com> Date: Tuesday, June 2, 2020 at 8:50 AM To: Aviva Lev-Ari <aviva.lev-ari@comcast.net> Subject: Re: […]

Read Full Post »

Clinical Trial for the Use of Nitric Oxide to Treat Severe COVID-19 Infection

Posted in COVID-19, FDA Regulatory Affairs, Frontiers in Cardiology and Cardiovascular Disorders, Nitric Oxide in Health and Disease, Population Health Management, Population Health Management, Genetics & Pharmaceutical, SARS-CoV-2, Virus Infective Acute Respiratory Syndrome: SARS-CoV on April 14, 2020| 2 Comments »


Clinical Trial for the Use of Nitric Oxide to Treat Severe COVID-19 Infection Reporter and Curator: Aviva Lev-Ari, PhD, RN   UPDATED 5/26/2020 Virology . 2009 Dec 5;395(1):1-9. doi: 10.1016/j.virol.2009.09.007. Epub 2009 Oct 1. Dual Effect of Nitric Oxide on SARS-CoV Replication: Viral RNA Production and Palmitoylation of the S Protein Are Affected Sara Akerström1, Vithiagaran Gunalan, Choong Tat […]

Read Full Post »

Next »